Reduction-Responsive Nanocarrier Co-delivery Indomethacin and Doxorubicin for Overcoming Multi-drug Resistant Breast Cancer

YAN Zhen-yu, WANG Xin-wei, MAI Chun-yang, SU Bo, ZHANG Zi-jie, HAN Ke

Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (11) : 925-932.

PDF(8864 KB)
PDF(8864 KB)
Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (11) : 925-932. DOI: 10.11669/cpj.2020.11.013

Reduction-Responsive Nanocarrier Co-delivery Indomethacin and Doxorubicin for Overcoming Multi-drug Resistant Breast Cancer

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 55(11): 925-932 https://doi.org/10.11669/cpj.2020.11.013

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(8864 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉